Why Medibank and NIB shares are outperforming today

Premium increases for 2024 have been announced.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) may be slipping into the red today, but the same cannot be said for Medibank Private Ltd (ASX: MPL) and NIB Holdings Limited (ASX: NHF) shares.

Both private health insurers are outperforming today with solid gains.

For example, Medibank shares are currently up 2% to $3.76, whereas NIB shares are up 3.5% to $7.85.

Health professional working on his laptop.

Image source: Getty Images

Why are Medibank and NIB shares outperforming?

Investors have been buying their shares this morning after the Australian Government gave the green light to premium increases in 2024.

According to a government release, the Albanese Government has approved an average industry premium increase of 3.03%.

Commenting on the increases, the release states:

The Albanese Government has ensured Australians get value for money from their private health insurance, with the average cost of private health insurance premiums rising at a much slower rate than the increase in wages, the age pension and inflation.

The 3.03 per cent increase is well below the annual rise in wages, social security payments and inflation, with wages rising by 4.2 per cent and inflation increasing by 4.1 per cent in 2023, and social security payments increasing in line with inflation.

NIB increases

NIB has been able to score a larger than average increase to its premiums.

An announcement this morning reveals that its 2024 health insurance premiums will rise by an average of 4.1% from 1 April 2024.

Its CEO, Mark Fitzgibbon, notes that the increase reflects the return of hospital and ancillary treatment post COVID-19, and a rise in health and medical treatment costs. He also highlights that claims inflation has moved back to long-term trends and believes it is crucial that insurers are able to price for this.

Mr Fitzgibbon commented:

We're not sitting back passively responding to inflationary pressure by just lifting premiums. We have a range of new measures designed to help members maintain good health as well as reduce out of pocket expenses. Essentially, we're trying to provide members with more value for their premiums.

Medibank will be increasing its premiums by a lower rate of 3.3% for 2024.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended NIB Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A woman with bright yellow hair wearing a brightly patterned blouse reacts to big news that she's reading on her phone.
Healthcare Shares

Historic: Here's why CSL shares are looking very interesting right now

CSL's yield now rivals a big four bank...

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

4DMedical shares jump 11% as investors cheer major US agreement

4DMedical has landed another commercial foothold in the US.

Read more »

A man and woman sit next to each other looking at each other and feeling excited and surprised after reading good news about their shares on a laptop.
Healthcare Shares

Which ASX healthcare stock could rise over 100% according to Bell Potter?

Let's see what the broker is saying about this stock this week.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

These 3 ASX healthcare stocks have been crushed in 2026. They could be set for a comeback

CSL is at a 10-year low. Cochlear has fallen 62%. ResMed is down on fears that proved wrong. Are any…

Read more »

A male doctor wearing a white lab coat shrugs his shoulders and holds his hands up in the air looking confused
Healthcare Shares

Should I buy CSL shares in June?

Here's what I expect from the beaten-down biotech stock next month.

Read more »

A man in a business suit holds his hand up to his mouth as though sharing a secret and gives a sly grin.
Healthcare Shares

After CSL's 60% share price crash, insiders are starting to buy

Insiders are buying after a brutal CSL share price fall.

Read more »

A man thinks very carefully about his money and investments.
Healthcare Shares

At under $100 each, Cochlear shares look like a bargain: Here's why

Cochlear Ltd (ASX: COH) shares have now crashed 63% for the year-to-date.

Read more »

A doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

3 ASX 200 shares I'd buy for the future of healthcare

Healthcare investing often requires patience, but I think the sector can produce some excellent long-term winners.

Read more »